FI853198L - PHARMACEUTICAL COMPOSITION INNEHAOLLANDE I VATTEN INSTABILA ELLER BEGRAENSAT LOESLIGA LAEKEMEDEL OCH FOERFARANDE FOER FRAMSTAELLNING AV DEM. - Google Patents

PHARMACEUTICAL COMPOSITION INNEHAOLLANDE I VATTEN INSTABILA ELLER BEGRAENSAT LOESLIGA LAEKEMEDEL OCH FOERFARANDE FOER FRAMSTAELLNING AV DEM.

Info

Publication number
FI853198L
FI853198L FI853198A FI853198A FI853198L FI 853198 L FI853198 L FI 853198L FI 853198 A FI853198 A FI 853198A FI 853198 A FI853198 A FI 853198A FI 853198 L FI853198 L FI 853198L
Authority
FI
Finland
Prior art keywords
loesliga
instabila
begraensat
vatten
eller
Prior art date
Application number
FI853198A
Other languages
Finnish (fi)
Other versions
FI853198A0 (en
FI86140C (en
FI86140B (en
Inventor
Bernhard Willi Werner Mueller
Ulrich Brauns
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6217510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI853198(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI853198A0 publication Critical patent/FI853198A0/en
Publication of FI853198L publication Critical patent/FI853198L/en
Application granted granted Critical
Publication of FI86140B publication Critical patent/FI86140B/en
Publication of FI86140C publication Critical patent/FI86140C/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The new pharmaceutical compositions according to the invention contain combination compounds of drugs which are unstable, or only sparingly soluble, in water, consisting of partially etherified β-cyclodextrin derivatives with hydroxyalkyl groups and possibly further alkyl groups.
FI853198A 1983-12-21 1985-08-20 Process for the preparation of a pharmaceutical preparation containing a water-insoluble or water-unstable drug FI86140C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19833346123 DE3346123A1 (en) 1983-12-21 1983-12-21 PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
DE3346123 1983-12-21
PCT/EP1984/000417 WO1985002767A1 (en) 1983-12-21 1984-12-20 Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
EP8400417 1984-12-20

Publications (4)

Publication Number Publication Date
FI853198A0 FI853198A0 (en) 1985-08-20
FI853198L true FI853198L (en) 1985-08-20
FI86140B FI86140B (en) 1992-04-15
FI86140C FI86140C (en) 1992-07-27

Family

ID=6217510

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853198A FI86140C (en) 1983-12-21 1985-08-20 Process for the preparation of a pharmaceutical preparation containing a water-insoluble or water-unstable drug

Country Status (17)

Country Link
EP (1) EP0149197B2 (en)
JP (1) JPS61500788A (en)
AT (1) ATE51145T1 (en)
AU (1) AU565966B2 (en)
CA (1) CA1222697A (en)
CY (1) CY1689A (en)
DE (2) DE3346123A1 (en)
DK (1) DK175288B1 (en)
FI (1) FI86140C (en)
HK (1) HK131293A (en)
HU (1) HU200943B (en)
LU (1) LU90283I2 (en)
NL (1) NL980009I1 (en)
NO (1) NO2000007I1 (en)
SG (1) SG24893G (en)
WO (1) WO1985002767A1 (en)
ZA (1) ZA8410042B (en)

Families Citing this family (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920214A (en) * 1986-04-16 1990-04-24 American Maize-Products Company Process for producing modified cyclodextrins
JPH0819004B2 (en) * 1986-12-26 1996-02-28 日清製粉株式会社 Sustained-release pharmaceutical preparation
IT1203968B (en) * 1987-04-24 1989-02-23 Bononi Ricerca B-CYCLODESTRINE COMPLEXES WITH ANTI-Fungal Activities
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
JP2577049B2 (en) * 1987-06-04 1997-01-29 三共株式会社 Cyclosporine preparation
NZ225045A (en) * 1987-07-01 1990-06-26 Janssen Pharmaceutica Nv Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
ZA884592B (en) * 1987-08-31 1989-03-29 Warner Lambert Co Cyclodextrin complexes of bis-biguanido hexane compounds
US4877774A (en) * 1987-09-09 1989-10-31 The United States Of America As Represented By The Department Of Health And Human Services Administration of steroid hormones
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
PL276595A1 (en) * 1987-12-22 1989-08-21 Glaxo Group Ltd Method of obtaining aqueous preparation containing derivative of piperidinylcyclopentylhexanecarboxylic-1 acid
US5221695A (en) * 1987-12-22 1993-06-22 Glaxo Group Limited Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
DE68901043D1 (en) * 1988-01-14 1992-04-30 Akzo Nv AQUEOUS PHARMACEUTICAL PREPARATION.
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
EP0398925B1 (en) * 1988-01-19 1993-10-20 Children's Hospital Corporation Growth inhibiting agent and the use thereof
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
US5637575A (en) * 1988-01-19 1997-06-10 The Trustees Of The University Of Pennsylvania Methods of inhibiting restenosis
AU626538B2 (en) * 1988-01-19 1992-08-06 Moses Judah Folkman Growth inhibiting agent and the use thereof
DE3809808A1 (en) * 1988-03-23 1989-10-05 Hexal Pharma Gmbh & Co Kg SOLIDS, ESPECIALLY FESTORAL AND RECTAL, ETOFENAMATE-CONTAINING MEDICINAL PRODUCTS
US5236944A (en) * 1988-03-28 1993-08-17 Janssen Pharmaceutica N.V. Compounds, compositions and anti-neoplastic methods
DE3815902A1 (en) * 1988-05-10 1989-11-23 Schwarz Pharma Gmbh Inclusion compounds of 1-(4-(2-(5-chloro-2-methoxybenzamido)ethyl)phenylsulphonyl)-3-cyclohex ylurea with alpha -, beta - and gamma -cyclodextrins, a pharmaceutical product containing these in each case, and process for the production thereof
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
NL8801670A (en) 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan PHARMACEUTICAL PREPARATION.
EP0381747A4 (en) * 1988-08-15 1991-09-11 American Maize-Products Company Water soluble branched beta cyclodextrin steroid complex
US5229370A (en) * 1988-08-15 1993-07-20 Ammeraal Robert N Water soluble branched beta cyclodextrin steroid complex
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
AU616571B2 (en) * 1988-10-28 1991-10-31 Shiseido Company Ltd. Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
JP2929108B2 (en) * 1988-10-28 1999-08-03 株式会社資生堂 Cosmetics and powder cosmetics
IT1227626B (en) * 1988-11-28 1991-04-23 Vectorpharma Int SUPPORTED DRUGS WITH INCREASED DISSOLUTION SPEED AND PROCEDURE FOR THEIR PREPARATION
US5441944A (en) * 1989-04-23 1995-08-15 The Trustees Of The University Of Pennsylvania Substituted cyclodextrin sulfates and their uses as growth modulating agents
GB8910069D0 (en) * 1989-05-03 1989-06-21 Janssen Pharmaceutica Nv Method of topically treating acne vulgaris
JPH0737390B2 (en) * 1989-08-29 1995-04-26 久光製薬株式会社 Ointment composition
EP0491812A4 (en) * 1989-09-14 1992-11-04 Australian Commercial Research & Development Limited Drug delivery compositions
US5053240A (en) * 1989-10-24 1991-10-01 Kalamazoo Holdings, Inc. Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
EP0518930A4 (en) * 1990-03-02 1993-09-15 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
FR2660309B1 (en) * 1990-03-27 1992-07-17 Roussel Uclaf NEW TIAPROFENIC ACID COMPLEXES OR ITS INSOLUBLE OR PARTIALLY SOLUBLE ESTERS WITH CYCLODEXTRINS OR DERIVATIVES THEREOF.
JP2867162B2 (en) * 1990-03-31 1999-03-08 株式会社資生堂 Peel-off type pack cosmetics
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5120720A (en) * 1990-09-20 1992-06-09 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers
LU87843A1 (en) * 1990-11-15 1992-08-25 Cird Galderma AQUEOUS GEL BASED ON RETINOIC ACID AND HYDROXYPROPYL-BETA-CYCLODEXTRIN AND ITS USE IN HUMAN MEDICINE AND COSMETICS
JPH04351603A (en) * 1991-05-29 1992-12-07 Toppan Printing Co Ltd Cyclodextrin derivative
EP0519428B1 (en) * 1991-06-21 2000-09-20 Takeda Chemical Industries, Ltd. Cyclodextrin compositions with fumagillol derivates
US5446030A (en) * 1991-09-19 1995-08-29 Weisz; Paul B. Prevention of hemolysis
ZA927923B (en) * 1991-10-16 1993-04-26 Schering Corp Lipophilic oligosaccharide antibiotic salt compositions.
IL103558A0 (en) 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
DE4207922A1 (en) * 1992-03-13 1993-09-23 Pharmatech Gmbh New water-soluble inclusion complexes contg randomly substd. methyl-beta-cyclodextrin - for admin. of substances which are only sparingly soluble in water
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
DE4227569C1 (en) * 1992-08-20 1994-06-09 Inst Chemo Biosensorik Enzymatic determn. of inorganic phosphate - using combination of di:saccharide phosphorylase, phosphatase or maltose synthase, and glucose oxido-reductase
TW251236B (en) * 1992-09-10 1995-07-11 Ciba Vision Ag
JP2879395B2 (en) * 1992-10-26 1999-04-05 富士写真フイルム株式会社 Anticancer composition containing rhodacyanine compound and cyclodextrin
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
ZA941544B (en) * 1993-03-05 1994-10-31 Hexal Pharma Gmbh Crystalline cyclodextrin complexes of ranitidine hydrochloride, process for their preparation and pharmaceutical compositions containing the same.
AU6553994A (en) * 1993-03-31 1994-10-24 Trustees Of The University Of Pennsylvania, The Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
DK94093D0 (en) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg LOCAL ANAESTHETIC PREPARATION
TW349870B (en) * 1993-09-30 1999-01-11 Janssen Pharmaceutica Nv An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof
RU2135176C1 (en) * 1993-12-14 1999-08-27 Эли Лилли Энд Компани Water-dissolved inclusion complex of benzothiophene compounds with water-soluble cyclodextrin, method of synthesis and pharmaceutical composition
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
WO1995025518A1 (en) * 1994-03-18 1995-09-28 Ciba-Geigy Ag Aqueous solution of levocabastine for ophthalmic use
DE4414138A1 (en) * 1994-04-22 1995-10-26 Consortium Elektrochem Ind Acylated gamma cyclodextrins
AU2531295A (en) * 1994-05-27 1995-12-21 Farmarc Nederland Bv Pharmaceutical composition
FR2726765B1 (en) * 1994-11-14 1996-12-20 Cis Bio Int RADIOPHARMACEUTICAL COMPOSITIONS COMPRISING A COMPLEX INCLUDING A CYCLODEXTRIN AND A RADIOHALOGEN FATTY ACID
US5576311A (en) * 1994-11-30 1996-11-19 Pharmos Corporation Cyclodextrins as suspending agents for pharmaceutical suspensions
FR2735136B1 (en) * 1995-06-08 1997-08-14 Roquette Freres PULVERULENT COMPOSITION OF HYDROXYPROPYL-BETACYCLODEXTRIN AND ITS PREPARATION PROCESS.
JP2920611B2 (en) * 1995-12-11 1999-07-19 株式会社シーエーシー Topical treatment for dermatitis
GB9605705D0 (en) 1996-03-19 1996-05-22 Pfizer Ltd Therapeutic agents
DE69733664T3 (en) 1996-04-19 2011-04-14 Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles Method of inactivating viruses and lyophilizing blood proteins
SE9601556D0 (en) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
JP4215277B2 (en) * 1996-08-09 2009-01-28 アルコン ラボラトリーズ，インコーポレイテッド Preservative system for pharmaceutical compositions containing cyclodextrin
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
KR19980033113A (en) * 1996-10-25 1998-07-25 야스다케 히지 Aqueous solutions of local anesthetics, how to improve the solubility of local anesthetics, local anesthetics with reduced neurotoxicity and methods of reducing the neurotoxicity of local anesthetics
HU224217B1 (en) * 1997-03-26 2005-06-28 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
US6596706B1 (en) 1997-11-07 2003-07-22 Daiichi Pharmaceutical Co., Ltd. Piperazine-cyclodextrin complexes
EP1039909B1 (en) 1997-12-31 2002-10-09 Choongwae Pharma Corporation Method of production and composition of an oral preparation of itraconazole
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
DE19848303A1 (en) * 1998-10-14 2000-04-20 Schering Ag Stable combination of 14,17-over-bridged steroid gestagen and cyclodextrin compound, useful for treating climacteric disorders or for contraception
GB9906126D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Pharmaceutical formulations
AU5975700A (en) * 1999-07-02 2001-01-22 Janssen Pharmaceutica N.V. Nasal formulation of an antifungal
SE9902988D0 (en) * 1999-08-24 1999-08-24 Astra Ab Chemical compounds
SI1278549T1 (en) 2000-05-02 2009-04-30 Theravance Inc Composition containing a cyclodextrin and a glycopeptide antibiotic
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
PE20020300A1 (en) 2000-08-22 2002-05-10 Pharmacia Corp COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD
US7074824B2 (en) 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6982256B2 (en) 2001-09-07 2006-01-03 Boehringer Ingelheim Pharma Kg Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
EP1443969A2 (en) 2001-10-18 2004-08-11 Decode Genetics EHF Non-inclusion cyclodextrin complexes
GB0127677D0 (en) * 2001-11-19 2002-01-09 Vianex S A Inclusion complex
US6881726B2 (en) 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
TW200400055A (en) 2002-02-22 2004-01-01 Pharmacia Corp Ophthalmic formulation with novel gum composition
US6951846B2 (en) * 2002-03-07 2005-10-04 The United States Of America As Represented By The Secretary Of The Army Artemisinins with improved stability and bioavailability for therapeutic drug development and application
US6818662B2 (en) 2002-05-28 2004-11-16 Taisho Pharmaceutical Co., Ltd. Pharmaceutical composition
DE10228049A1 (en) 2002-06-24 2004-01-15 Merck Patent Gmbh Liquid preparation containing oligopeptides
DK2272503T3 (en) 2003-03-28 2013-05-21 Ares Trading Sa Oral formulations of cladribine
EP1608343B1 (en) 2003-03-28 2016-04-27 Ares Trading S.A. Cladribine formulations for improved oral and transmucosal delivery
UA81305C2 (en) 2003-07-02 2007-12-25 Ares Trading Sa Formulation of cladribine (variants), cladribine-cyclodextrin complex, use of cladribine-cyclodextrin complex, mixture
CN1294912C (en) * 2004-03-01 2007-01-17 上海医药工业研究院 Itraconazole hydrochloride composition and freeze-dried powder injection thereof
DE102004011512B4 (en) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
ITMI20041763A1 (en) * 2004-09-16 2004-12-16 Altergon Sa NEW INJECTABLE FORMULATIONS CONTAINING PROGESTERONE
WO2006137433A1 (en) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. Aqueous preparation having levocabastine solubilized therein
US7744904B1 (en) * 2005-09-26 2010-06-29 B.B. Scientific L.L.C. Stabilization of Clostridium botulinum neurotoxin complex
CA2660086C (en) 2006-08-16 2014-09-16 Novartis Ag Method of making solid dispersions of highly crystalline therapeutic compounds
AU2007325576B2 (en) * 2006-10-20 2013-01-10 Icos Corporation Compositions of Chk1 inhibitors
EP1920785A1 (en) * 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
KR20090087079A (en) * 2006-11-21 2009-08-14 노파르티스 아게 Stable parenteral formulation containing a rsv inhibitor of a benzodiazepine structure
PE20091432A1 (en) * 2008-02-28 2009-10-17 Takeda Pharmaceutical PHARMACEUTICAL COMPOSITION
ES2436716T3 (en) 2008-11-25 2014-01-03 Boehringer Ingelheim Vetmedica Gmbh Pimobendan for use in the treatment of hypertrophic cardiomyopathy in cats
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
CN102499909B (en) * 2011-12-27 2013-08-07 哈尔滨三联药业有限公司 Itraconazole dispersible tablets and preparation method thereof
KR101383941B1 (en) * 2012-03-09 2014-04-10 동아에스티 주식회사 Stable pharmaceutical composition containing piroxicam or its pharmaceutical acceptable salt and hyaluronic acid and its pharmaceutical acceptable salt and their manufacturing method thereof
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
PT2866802T (en) * 2012-06-28 2016-09-05 Johnson & Johnson Consumer Inc Racecadotril liquid compositions
CN105189546B (en) * 2013-03-13 2022-09-02 西雅图基因公司 Cyclodextrin and antibody-drug conjugate formulations
CN113181110A (en) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 Liquid aqueous pharmaceutical composition containing preserved etherified cyclodextrin derivatives
ES2750246T3 (en) * 2013-10-08 2020-03-25 Innopharma Inc Aprepitant oral liquid formulations
BR112016011111B1 (en) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh IMPROVED PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
RS64029B1 (en) * 2017-06-30 2023-03-31 Celgene Corp Compositions and methods of use of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl) -2,2-difluoroacetamide
US10716774B1 (en) 2018-01-05 2020-07-21 Yale Pharmaceuticals LLC Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability
FR3083234B1 (en) * 2018-06-29 2020-11-27 Roquette Freres NEW HYDROXYPROPYL-BETA-CYCLODEXTRINS AND THEIR PREPARATION METHODS
WO2020002851A1 (en) * 2018-06-29 2020-01-02 Roquette Freres NOVEL HYDROXYPROPYL-β-CYCLODEXTRIN AND PROCESS FOR THE PRODUCTION THEREOF
CA3114021A1 (en) 2018-10-29 2021-05-07 Cyclo Therapeutics, Inc. Methods for treating alzheimer's disease
CN114195733B (en) * 2022-01-07 2024-10-01 华东理工大学 Method for inhibiting isomerization of probenazole

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) * 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
US3453259A (en) * 1967-03-22 1969-07-01 Corn Products Co Cyclodextrin polyol ethers and their oxidation products
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids

Also Published As

Publication number Publication date
AU565966B2 (en) 1987-10-01
SG24893G (en) 1993-08-06
EP0149197B1 (en) 1990-03-21
CA1222697A (en) 1987-06-09
HUT40561A (en) 1987-01-28
AU3835285A (en) 1985-07-12
DK359585A (en) 1985-08-07
EP0149197A3 (en) 1985-08-14
DK175288B1 (en) 2004-08-09
JPH0570612B2 (en) 1993-10-05
NL980009I1 (en) 1998-05-06
HK131293A (en) 1993-12-03
NO2000007I1 (en) 2000-09-21
DK359585D0 (en) 1985-08-07
LU90283I2 (en) 1998-11-03
DE3346123A1 (en) 1985-06-27
CY1689A (en) 1994-01-14
ZA8410042B (en) 1985-09-25
FI853198A0 (en) 1985-08-20
FI86140C (en) 1992-07-27
WO1985002767A1 (en) 1985-07-04
DE3481680D1 (en) 1990-04-26
ATE51145T1 (en) 1990-04-15
JPS61500788A (en) 1986-04-24
EP0149197B2 (en) 1997-01-08
FI86140B (en) 1992-04-15
EP0149197A2 (en) 1985-07-24
HU200943B (en) 1990-09-28

Similar Documents

Publication Publication Date Title
FI853198L (en) PHARMACEUTICAL COMPOSITION INNEHAOLLANDE I VATTEN INSTABILA ELLER BEGRAENSAT LOESLIGA LAEKEMEDEL OCH FOERFARANDE FOER FRAMSTAELLNING AV DEM.
IL56369A (en) Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
FI793689A (en) HYDROXIETYL-AZOLER FOERFARANDE FOER FRAMSTAELLNING AV DEM SAMT DERAS ANVAENDNING SOM LAEKEMEDEL
BR9709654A (en) Derivatives of thiazolidine-2,4-dione replaced their processes of obtaining and the pharmaceutical compositions containing them
FI793688A (en) HYDROXIPROPYL-TRIAZOLE FOERFARANDE FOER FRAMSTAELLNING AV DEM OCH DERAS ANVAENDNING SOM LAEKEMEDEL
NO842665L (en) BIOPOLYMERS AND PROCEDURES FOR THEIR PREPARATION
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
IT8021370A0 (en) THEOPHYLLINMETHYLDIOXOLANE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
NO914077L (en) GALACTOM MANNER DERIVATIVES FOR ENVIRONMENT OR INHIBITION OF ACTIVE INGREDIENTS IN PHARMACEUTICALS
MX6424A (en) DERIVATIVES OF TRIPEPTIDES, PROCEDURES FOR THE PREPARATION OF DERIVATIVES OF TRIPEPTIDES AND COMPOSITIONS THAT CONTAIN THEM.
MX9203613A (en) DERIVATIVES OF ADENOSINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
FI800350A (en) DEHYDROPEPTIDER FOERFARANDE FOER FRAMSTAELLNING AV DESSA SAMT ANVAENDNINGEN AV DESSA SOM LAEKEMEDEL
OA08130A (en) Pharmaceutical or veterinary compositions containing thiosulfonate derivatives.
IT8022188A0 (en) NICOTINE DERIVATIVES OF GLUCOSAMINE, PROCEDURE FOR THE PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
IT8026131A0 (en) PIPERAZINE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
FI793035A (en) NYA 2-SUBSTITUERADE-3-HETEROCYCLYL-INDOLES DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
MX9102683A (en) DERIVATIVES OF CEPHALOSPORIN, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
IT8123611A0 (en) DERIVATIVES OF AMINOTIOLS, THEIR PREPARATION AND THEIR USE AND ALSO COMPOSITIONS CONTAINING THESE DERIVATIVES.
FR2531084B1 (en) NOVEL 7- (4-PYRIDYL) -1,8-NAPHTYRIDINE DERIVATIVES, MEDICAMENT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IT8422568A0 (en) DIHYDROARYLOXYALKYLAMINO-1,2,4-TRPROCEDURE FOR THE PREPARATION OF IAZOLE. DERIVATIVES OF
MX9203235A (en) DERIVATIVES OF TETRAHIDRONAFTALENO AND INDANO AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IT8119210A0 (en) PENICILLAN AND CEPHALOSPORAN DERIVATIVES AND RELATED PHARMACEUTICAL COMPOSITIONS.
IT8124843A0 (en) SALICYLIC DERIVATIVES OF ALPHA-MERCAPTOPROPIONILGLYCINE, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
NO913502L (en) COMPOSITION FOR USE AS HIGH-ENERGY EXPLANATOR OR FUEL.
ATE7385T1 (en) DERIVATIVES OF 2-HYDROXYOXALACIDEANILIDE AND THEIR SALTS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Legal Events

Date Code Title Description
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L127

Extension date: 20091220

FG Patent granted

Owner name: JANSSEN PHARMACEUTICA N.V.